Jury Considers Record $6 Billion Payout in Major Preterm Infant Formula Lawsuit Against Abbott, Reckitt’s Mead
In a significant legal escalation, attorneys representing numerous families impacted by alleged defective preterm infant formula are seeking damages exceeding $6 billion from health care company Abbott Laboratories and consumer goods manufacturer Reckitt. The lawsuit underlines grave concerns over the safety and consequences of the infant formula products these families have trusted. The case, spotlighting two major brands, Abbott’s Similac and Reckitt’s Enfamil, claims these products contributed adversely to the health of newborns, necessitating comprehensive medical attention and extended hospital stays. Representatives for the families contend that these formulas, specifically marketed for premature infants, have … Read more